Circulating activity levels of IFN types were then determined in 56 healthy controls and 191 patients with SLE from the “study of biological pathways, disease activity and response markers in patients with SLE” (SPARE).41 This evidence concerns the gene IFNA1 and systemic lupus erythematosus.